preterm labor. Preterm labour and delivery
Conditions
Interventions
Intervention 1: Intervention: 17-a-OH-p (proloton), IM, weekly. Intervention 2: Control: vaginal suppository of progestrone, 100mg, daily.
Treatment - Drugs
Intervention: 17-a-OH-p (proloton), IM, weekly
Control: vaginal suppository of progestrone, 100mg, daily
Sponsors
Hamadan university of medical sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 42 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: all high risk women for pre-term labour including: recurrent abortion, pre tem labour history, cervical rippening, etc. Exclusion criteria: Epileptic and asthmatic subjects; those with uncontrolled diabetes; those who were sensitive to progesterone; those who have received progesterone four weeks before the study; mental illness; chronic HTN; active liver disorder; HIV infection or 35> CD4 count and anti-viral drug recipients; placenta previa; history of genital and breast cancer; history of thromboembolic disease and mullerian anomaly; ultrasound diagnosed major anomaly; recognized fetal chromosomal abnormalities; Multiple cerclage and preterm labor and PROM and clinical chorioamnionitis; vaginal bleeding and history of spontaneous preterm labor without delivery (including preterm labor).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preterm labor. Timepoint: monthly. Method of measurement: questionnaire and physical exam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Delivery type. Timepoint: monthly. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrangiz Zamani
Hamadan university of medical sciences
Outcome results
None listed